Response Genetics, Inc. (NASDAQ:RGDX)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $2.11 |
| Daily Range | $2.10 - $2.20 |
| 52-Week Range | $0.81 - $3.05 |
| Market Cap | $41.03M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 59,288 |
| Average Daily Volume | 0 |
RGDX
VS S&P 500 (SPY)
RGDX News and Commentary
- Response Genetics Test Target Patients That Xalkori Can Help – SmartMoney
- A Simplified ASCO 2011 List for Biotech Investor Research – SeekingAlpha
- Tuesday's Highs & Lows – Blog at The Motley Fool
- UPDATE 1-Response Genetics inks deal with Glaxo, shares soar – Reuters
Related News and Articles
- Does This Hostile Takeover Make Sense? – The Motley Fool
- Illuminating the Way Forward for Genomics – The Motley Fool
- Life Technologies' Sequence of Success – The Motley Fool
This ticker is not currently Ratable.
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
2
Outperform
0
Underperform
All-Star Players
1
Outperform
0
Underperform
Wall Street
0
Outperform
0
Underperform
RSS Headlines
Fool UK
